Funds · 13F filer · Washington, DC

Carlyle Group Inc.

$10.0B in 19 U.S. stocks and ETFs at the end of June 30, 2026, as reported to the SEC.1

1y return−13.5%S&P 500 +20.9%

These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.

$100 invested in its stock picks

Since March 31, 2025: $102 against $133 in the S&P 500.2

Carlyle Group Inc.S&P 500 (SPY)
$100$13320252026

Top holdings

At the end of June 30, 2026. Change is in shares since the quarter before.2

StockValueShare of portfolioChange
MDLNMedline Inc$7.4B73.8%
SAROStandardaero Inc$2.5B25.3%
PHATPhathom Pharmaceuticals Inc$37.9M0.4%
INVHInvitation Homes Inc$20.0M0.2%
PONYPony Ai Inc$16.4M0.2%
GETYGetty Images Holdings Inc$5.4M0.1%
SPRBSpruce Biosciences Inc$2.1M0.0%
SPWRSunPower Inc$1.6M0.0%+441.1%
ACETAdicet Bio Inc$1.6M0.0%
FWRDForward Air Corp$1.4M0.0%
OKUROnkure Therapeutics Inc$1.2M0.0%
DNUTKrispy Kreme Inc$1.2M0.0%
QTTBQ32 Bio Inc$769K0.0%−94.5%
REPXRiley Exploration Permian In$530K0.0%New
Nebius Group N.V.CUSIP N97284108$510K0.0%New
HOODRobinhood Mkts Inc$475K0.0%+40.2%
JSPRJasper Therapeutics Inc$449K0.0%
NABLN-able Inc$344K0.0%
METCRamaco Res Inc$288K0.0%New

Best picks still held

How each current holding has done since the quarter it first appeared in its filings (up to six years back).

StockHeld sinceReturn sinceNow worth
PHATPhathom Pharmaceuticals IncMarch 31, 2023+52.0%$37.9M
SAROStandardaero IncDecember 31, 2024+20.8%$2.5B
ACETAdicet Bio IncDecember 31, 2025+2.6%$1.6M
INVHInvitation Homes IncMarch 31, 2023−3.3%$20.0M
MDLNMedline IncDecember 31, 2025−6.1%$7.4B
HOODRobinhood Mkts IncDecember 31, 2025−11.3%$475K
FWRDForward Air CorpJune 30, 2025−44.9%$1.4M
OKUROnkure Therapeutics IncDecember 31, 2024−47.0%$1.2M
PONYPony Ai IncDecember 31, 2024−51.6%$16.4M
SPWRSunPower IncSeptember 30, 2023−66.6%$1.6M

Sold off last quarter

  • CUBECubeSmart was $8.1M
  • HTFLHeartflow Inc was $497K
  • SYRESpyre Therapeutics Inc was $485K
  • XCURExicure Inc was $240K

Quarter by quarter

QuarterIts picksS&P 500
June 30, 2026−5.6%+14.8%
March 31, 2026+0.5%−4.6%
December 31, 2025+4.8%+2.4%
September 30, 2025−13.0%+7.8%
June 30, 2025+18.0%+10.5%
December 31, 2024−10.1%+2.1%
September 30, 2024+27.6%+5.4%
June 30, 2024−19.6%+4.0%
March 31, 2024−19.0%+10.0%
December 31, 2023+6.4%+11.2%
September 30, 2023−19.5%−3.6%
June 30, 2023+3.3%+8.3%
March 31, 2023−4.1%+7.0%
December 31, 2022−7.8%+7.1%
June 30, 2022−21.8%−16.5%
March 31, 2022−11.9%−4.9%
September 30, 2021+0.1%+0.3%

Sources

Every number on this page points here. Each one links to the public record.

  1. 1
    CIK 1527166
  2. 2
    Filed August 7, 2026 · accession 0000898432-26-000602